Prior Authorization/Referral
Some covered services or medications may need approval from Meridian, and this is called a Prior Authorization (PA). You do not need a paper referral from Meridian to see a provider but your provider may need to request a prior authorization from Meridian for a service to be approved.
The recently passed Prior Authorization Reform Act is helping us make our services even better. This bill took effect January 1, 2022.
Our prior authorization process will see many improvements. We will be more clear with processes. And we will reduce wait times for things like tests or surgeries. You will also see improved fairness with our PA process.
Our current PA process is NCQA certified. It meets many of the new law's standards. However, we see this as a time to continue improving our services.
For clinical criteria, please see the information linked below. To request PA information or receive additional support, please contact us at 866-606-3700 (TTY: 711).
Below is a list of services that require prior authorization from Meridian before your healthcare provider can proceed with treatment.
SERVICES THAT REQUIRE A PRIOR AUTHORIZATION | PRIOR AUTHORIZATION REQUIRED FOR SOME OR ALL OF THE SERVICES? |
---|---|
Ambulatory Surgery Center | Some services require prior authorization |
Bariatric Surgery (Certain restrictions and limitations may apply) | Yes |
Birthing Centers | Yes |
Durable Medical Equipment (DM) | Some items require prior authorization |
High Cost Radiology | Yes |
Home Health Care Services | Yes |
Hospice Care | Yes |
Hospital Services Inpatient | Yes |
Hospital Services Outpatient | Some services require prior authorization |
Laboratory Services (HPP): All services necessary for the diagnosis, treatment and prevention of disease, and for the maintenance of health. | Some services require prior authorization |
Maternity Services (HPP) | Some services require prior authorization |
Medical Services Clinic | Yes |
Orthotics & Prosthetics (O&P): Braces (non-dental) and other mechanical or molded devices to support or correct any defect of form or function of the human body. | Yes |
Oxygen & Respiratory Services (HPP) | Some services require prior authorization |
Pain Managment | Some services require prior authorization |
Substance Use Disorder Services (HPP_ | Some services require prior authorization |
Therapy (OT,PT,ST) Services (Outpatient) | Yes |
Transplant Services | Yes |
All such services determined by Illinois Medicaid to be medically necessary shall constitute a Meridian Covered Service. See the Meridian Member Handbook for more information on coverage out-of-network and out of the Illinois Meridian service area.
Do I need a referral to see a specialist?
No, you do not need a referral from your PCP to see a specialist. You do not need a referral for routine vision care, chiropractic services, or mental health/counseling services.
- 184 Factor VIII (PDF)
- Abaloparatide (Tymlos) (PDF)
- Abatacept (Orencia) (PDF)
- Aclidinium/Formoterol (Duaklir Pressair) (PDF)
- Acute and Chronic Opioid Therapy Policy (PDF)
- Adakevo (PDF)
- Adalimumab (Humira), Adalimumab-atto (Amjevita), Adalimumab-adbm (Cyltezo), Adalimumab-bwwd (Hadlima), Adalimumab-adaz (Hyrimoz) (PDF)
- Adefovir (Hepsera) (PDF)
- Aflibercept (Eylea) (PDF)
- Alemtuzumab (Lemtrada) (PDF)
- Alirocumab (Praluent) (PDF)
- Alpha 1-Proteinase Inhibitors (PDF)
- Ambrisentan (Letairis) (PDF)
- Anakinra (Kineret) (PDF)
- Apremilast (Otezla) (PDF)
- Aripiprazole Long-Acting Injection (Abilify Maintena, Aristada, Aristada Initio) (PDF)
- Avatrombopag (Doptelet) (PDF)
- Axitinib (Inlyta) (PDF)
- Aztreonam (Cayston) (PDF)
- Baricitinib (Olumiant) (PDF)
- Belimumab (Benlysta) (PDF)
- Benralizumab (Fasenra) (PDF)
- Betamethasone Dipropinate (Sernivo) (PDF)
- Bevacizumab (Avastin, Mvasi, Zirabev) (PDF)
- Brodalumab (Siliq) (PDF)
- Budesonide/Glycopyrrolate/Formoterol Fumarate (Breztri Aerosphere) (PDF)
- C1 Esterase Inhibitors (Berinert, Cinryze, Haegarda, Ruconest) (PDF)
- Calcipotriene-Betamethasone Dipropionate Foam (Enstilar) (PDF)
- Cladribine (Mavenclad) (PDF)
- Certolizumba (Cimzia) (PDF)
- Clozapine (Fazaclo) (PDF)
- Clobazam (Onfi, Sympazan) (PDF)
- Colesevelam (Welchol) (PDF)
- Continuous Glucose Monitors (PDF)
- Contimuous Glucose Monitor Criteria (Dexcom) (PDF)
- Continuous Insulin Delivery Systems (Omnipod, Omnipod DASH) (PDF)
- Darbepoetin Alfa (Aranesp) (PDF)
- Dasabuvir/Ombitasvir/Paritaprevir/Ritonavir (Viekira Pak) (PDF)
- Deferasirox (Exjade, Jadenu) (PDF)
- Deferiprone (Ferriprox) (PDF)
- Delafloxacin (Baxdela) (PDF)
- Denosumab (Prolia, Xgeva) (PDF)
- Dermatology Class Criteria (PDF)
- Dimethyl Fumarate (Tecfidera), Diroximel Fumarate (Vumerity), Monomethyl Fumarate (Bafiertam) (PDF)
- Doxepin (Silenor) (PDF)
- Dipeptidyl Peptidase-4 (DPP-4) Inhibitors (PDF)
- Eculizumab (PDF)
- Efinaconazole (Jublia) (PDF)
- Elagolix (Orilissa), Elagolix/Estradiol/Norethinedrone (Oriahnn) (PDF)
- Elbasvir/Grazoprevir (Zepatier) (PDF)
- Eltrombopag (Promacta) (PDF)
- Emtricitabine/Tenofovir Alafenamide (Descovy) (PDF)
- Endari (PDF)
- Epoetin Alfa (Epogen, Procrit), Epoetin Alfa-epbx (Retacrit) (PDF)
- Epoprostenol (Flolan, Veletri) (PDF)
- Erenumab-aaoe (Aimovig) (PDF)
- Esketamine (Spravato) (PDF)
- Everolimus (Afinitor, Afinitor Disperz, Zortress) (PDF)
- Evolocumab (Repatha) (PDF)
- Farxiga (PDF)
- Fentanyl IR (Abstral, Actiq, Fentora, Lazanda, Subsys) (PDF)
- Ferric Maltol (Accrufer) (PDF)
- Filgrastim (Neupogen), Filgrastim-sndz (Zarxio), Tbo-filgrastim (Granix), Filgrastim-aafi (Nivestym) (PDF)
- Fingolimod (Gilenya) (PDF)
- Fluticasone Propionate (Xhance) (PDF)
- Fluticasone/Salmeterol (Advair Diskus, Advair HFA) (PDF)
- Fluticasone/Umeclidinium/Vilanterol (Trelegy Ellipta) (PDF)
- Fluticasone/Vilanterol (Breo Ellipta) (PDF)
- Formulary Exceptions (PDF)
- Fremanezumab-vfrm (Ajovy) (PDF)
- Gastrointestinal Agents (PDF)
- Gilteritinib (Xospata) (PDF)
- Glatiramer Acetate (Copaxone, Glatopa) (PDF)
- Glecaprevir/Pibrentasvir (Mavyret) (PDF)
- Global Medical Necessity (PDF)
- Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists (PDF)
- Golimumab (Simponi, Simponi Aria) (PDF)
- Guselkumab (Tremfya) (PDF)
- Human Growth Hormone (Somapacitan, Somatropin) (PDF)
- Hyaluronate Derivatives (PDF)
- Ibalizumab-uiyk (Trogarzo) (PDF)
- Icatibant (Firazyr) (PDF)
- Icosapent Ethyl (Vascepa) (PDF)
- Immune Globulins (PDF)
- Indacaterol/Glycopyrrolate (Utibron Neohaler) (PDF)
- Infliximab (Remicade), Infliximab-axxq (Avsola), Infliximab-dyyb (Inflectra), Infliximab-abda (Renflexis) (PDF)
- Insulin Delivery Systems (V-Go, Omnipod, InPen) (PDF)
- Interferon Beta-1a (Avonex, Rebif) (PDF)
- Interferon Beta-1b (Betaseron, Extavia) (PDF)
- Interferon Gamma-1b (Actimmune) (PDF)
- Isotretinoin (Claravis, Absorica, Absorica LD, Myorisan, Zenatane) (PDF)
- Istradefylline (Nourianz) (PDF)
- Isturisa (PDF)
- Itraconazole (Sporanox) (PDF)
- Ixekizumab (Taltz) (PDF)
- Lasmiditan (Reyvow) (PDF)
- Lacosamide (Vimpat) (PDF)
- Lanadelumab-fylo (Takhzyro) (PDF)
- Ledipasvir/Sofosbuvir (Harvoni) (PDF)
- Linezolid (Zyvox) (PDF)
- Lomitapide (Juxtapid) (PDF)
- Lusutrombopag (Mulpleta) (PDF)
- Mecasermin (Increlex) (PDF)
- Med Neces for Drug not PDL (PDF)
- Mepolizumab (Nucala) (PDF)
- Methoxy Polyethylene Glycol-epoetin Beta (Mircera) (PDF)
- Migraine Prophylaxis – Preferred Agents (PDF)
- Milrinone (PDF)
- Mipomersen (Kynamro) (PDF)
- Mitoxantrone (Novantrone) (PDF)
- Mometasone Furoate (Sinuva) (PDF)
- Natalizumab (Tysabri) (PDF)
- Nintedanib (Ofev) (PDF)
- Non-Calcium Phosphate Binders (PDF)
- Non-Formulary Injectable Antibiotics (PDF)
- Non-Preferred Blood Glucose Monitors/Test Strips (PDF)
- Ocrelizumab (Ocrevus) (PDF)
- Octreotide Acetate (Sandostatin Injection, Sandostatin LAR Depot, Bynfezia, Mycapssa) (PDF)
- Olanzapine Long-Acting Injection (Zyprexa Relprevv) (PDF)
- Opioid Analgesics (PDF)
- Overactive Bladder Agents (PDF)
- Oxbryta (PDF)
- Ozanimod (Zeposia) (PDF)
- Paliperidone Long-Acting Injection (Invega Sustenna, Invega Trinza) (PDF)
- Pegfilgrastim (Neulasta), Pegfilgrastim-jmdb (Fulphila), Pegfilgrastim-cbqv (Udenyca), Pegfilgrastim-bmez (Ziextenzo), Pegfilgrastin-apgf (Nyvepria) (PDF)
- Peginterferon Alfa-2a,b (Pegasys, PegIntron, Sylatron) (PDF)
- Peginterferon Beta-1a (Plegridy) (PDF)
- Pegloticase (Krystexxa) (PDF)
- Perampanel (Fycompa) (PDF)
- Pirfenidone (Esbriet) (PDF)
- Pitolisant (Wakix) (PDF)
- Propranolol HCl Oral Solution (Hemangeol) (PDF)
- Ranibizumab (Lucentis) (PDF)
- Rasburicase (Elitek) (PDF)
- Request for Exceptions to the Formulary (PDF)
- Request for Non-Preferred Formulary Agents (PDF)
- Rifaximin (Xifaxan) (PDF)
- Rimegepant (Nurtec ODT) (PDF)
- Risankizumab-rzaa (Skyrizi) (PDF)
- Risperidone Long-Acting Injection (Perseris, Risperdal Consta) (PDF)
- Rituximab (Rituxan), Rituximab-pvvr (Ruxience), Rituximab-abbs (Truxima), Rituximab-Hyaluronidase (Rituxan Hycela) (PDF)
- Rivastigmine (Exelon) (PDF)
- Romiplostim (Nplate) (PDF)
- Romosozumab-aqqg (Evenity) (PDF)
- Rufinamide (Banzel) (PDF)
- Safinamide (Xadago) (PDF)
- Sapropterin Dihydrochloride (Kuvan) (PDF)
- Sarilumab (Kevzara) (PDF)
- Satralizumab-mwge (Enspryng) (PDF)
- Secukinumab (Cosentyx) (PDF)
- Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors (PDF)
- Siponimod (Mayzent) (PDF)
- Sodium Oxybate (Xyrem) and Calcium, Magnesium, Potassium, and Sodium Oxybate (Xywav) (PDF)
- Sofosbuvir (Sovaldi) (PDF)
- Sofosbuvir/Velpatasvir (Epclusa) (PDF)
- Sofosbuvir/Velpatasvir/Voxilaprevir (Vosevi) (PDF)
- Solriamfetol (Sunosi) (PDF)
- Sunosi (PDF)
- Suvorexant (Belsomra) (PDF)
- Tadalafil (Adcirca, Alyq) (PDF)
- Taliglucerase Alfa (Elelyso) (PDF)
- Tasimelteon (Hetlioz, Hetlioz LQ) (PDF)
- Tazarotene (Arazlo, Fabior, Tazorac) (PDF)
- Teduglutide (Gattex) (PDF)
- Tegaserod (Zelnorm) (PDF)
- Tepezza (PDF)
- Trastuzumab/Biosimilars, Trastuzumab-Hyaluronidase (PDF)
- Teriflunomide (Aubagio) (PDF)
- Teriparatide (Forteo) (PDF)
- Testosterone (PDF)
- Tildrakizumab-asmn (Ilumya) (PDF)
- Tiotropium/Olodaterol (Stiolto Respimat) (PDF)
- Tocilizumab (Actemra) (PDF)
- Triamcinolone ER Injection (Zilretta) (PDF)
- Ubrogepant (Ubrelvy) (PDF)
- Umeclidinium/Vilanterol (Anoro Ellipta) (PDF)
- Upadacitinib (Rinvoq) (PDF)
- Ustekinumab (Stelara) (PDF)
- Vedolizumab (Entyvio) (PDF)
- Verteporfin (Visudyne) (PDF)
- Vigabatrin (Sabril) (PDF)
- Vyepti (PDF)
- Wakix (PDF)
- Zoledronic Acid (Reclast, Zometa) (PDF)